# Clinical outcomes and revision strategies following failed internal fixation of peri-trochanteric femoral fractures: a retrospective cohort study

**Authors:** Yujie Zhang, Fan Yang, Chaorong Yu, Hanxiao Zhu, Erman Chen, Hang Li, Weixu Li

PMC · DOI: 10.3389/fmed.2026.1773816 · Frontiers in Medicine · 2026-03-04

## TL;DR

This study examines failed hip fracture surgeries and proposes tailored revision strategies to improve patient outcomes.

## Contribution

A classification system and treatment protocols for revision surgeries following failed internal fixation of peri-trochanteric femoral fractures.

## Key findings

- Four categories of surgical failure were identified based on patient characteristics and implant conditions.
- Tailored revision strategies improved imaging results and functional scores in patients.
- Joint replacement surgeries had shorter operation times and less blood loss compared to other revision types.

## Abstract

Revision surgery for femoral peri-trochanteric fractures is a complex and high-risk intervention. This study aimed to systematically examine the multifaceted etiologies of primary internal fixation failures, classify them into distinct categories, and develop tailored revision strategies to enhance overall management and optimize clinical outcomes in peri-trochanteric fracture cases.

We conducted a retrospective study of 141 peri-trochanteric fractures with failed internal fixation surgery between 2013 and 2023. The cohort comprised 87 males and 54 females, with a mean age of 60.34 ± 16.02 years. Of these, 96 were intertrochanteric fractures classified by the Arbeitsgemeinschaft für Osteosynthesefragen/Orthopedic Trauma Association (AO/OTA) system (28 type A1, 20 type A2, and 48 type A3), and 45 were subtrochanteric fractures classified by the Seinheimer system. We conducted an in-depth analysis of failure mechanisms and subsequently categorized the patients into four groups, each with distinct revision procedures.

The average follow-up time was 15.96 ± 5.61 months. The joint replacement group had a significantly higher mean age (72.13 ± 13.00 years) than the revision internal fixation group (P < 0.05). The average revision surgery duration was 143.06 ± 57.29 min, with the joint replacement group having significantly shorter operation times (107.50 ± 41.40 min, P < 0.01), which were comparable to those of the type I revision group. Intraoperative blood loss averaged 344.26 ± 335.43 ml, with the type I and joint replacement revision group showing the least blood loss (P < 0.01). The mean healing duration was 7.08 ± 3.33 months. Harris hip scores improved from 24.78 ± 6.08 pre-operatively to 80.59 ± 4.54 post-operatively. Patients who underwent type IV revisions had significantly lower scores (P < 0.05).

We classified peri-trochanteric fracture surgical failures into four distinct categories based on age, presence of infection, integrity of the femoral head and acetabulum, varus deformity, and implant condition. We developed detailed diagnostic and treatment protocols for each category. Adhering to our established protocols, the imaging results and functional scores of all patients were consistently favorable. Our comprehensive treatment strategy can serve as a critical reference for standard revision procedures in the management of peri-trochanteric fractures.

## Full-text entities

- **Diseases:** peri (MESH:D057873), femoral fractures (MESH:D005264), blood loss (MESH:D016063), varus deformity (MESH:D060905), intertrochanteric fractures (MESH:D006620), infection (MESH:D007239), Orthopedic Trauma (MESH:D009140)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12996186/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12996186/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12996186/full.md

---
Source: https://tomesphere.com/paper/PMC12996186